Cancer BiologybioRxiv
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
A. J. Arribas, S. Napoli, L. Cascione…·F. Bertoni
This study identifies ERBB4-mediated signaling as a mechanism of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms and shows that targeting ERBB signaling can restore sensitivity.
DOI 10.1158/1535-7163.mct-23-0068